DREADD Agonist 21 – 10 mg

Brand:
Cayman
CAS:
56296-18-5
Storage:
-20
UN-No:
Non-Hazardous - /

DREADD agonist 21 activates hM3Dq (EC50 = 1.7 nM), a designer receptor exclusively activated by designer drugs (DREADD) derived from the human muscarinic acetylcholine M3 receptor.{30413} It does not agonize the hM3 receptor and displays relatively weaker binding affinities for serotonin 5-HT2A, 5-HT2C, α1A-adrenergic, and histamine H1 receptors (Kis = 66, 170, 280, and 6 nM, respectively).{30413}  

 

Available on backorder

SKU: - Category:

Description

Selectively activates hM3Dq (EC50 = 1.7 nM), a DREADD derived from the human muscarinic acetylcholine M3 receptor


Formal name: 11-​(1-​piperazinyl)​-​5H-​​dibenzo[b,​e]​​[1,​4]​​diazepine

Synonyms: 

Molecular weight: 278.4

CAS: 56296-18-5

Purity: ≥98%

Formulation: A crystalline solid


Product Type|Biochemicals|Receptor Pharmacology|Agonists||Research Area|Neuroscience|DREADD Research